Tower Research Capital (TRC)’s iPath Pure Beta S&P GSCI-Weighted ETN SBV Stock Holding History
Bought
Maintained
Sold
Other funds holding SBV
Tower Research Capital (TRC)'s SBV Position: Q2 2014 in Review
Tower Research Capital (TRC) sold out of iPath Pure Beta S&P GSCI-Weighted ETN (SBV) in Q2 2014, closing a stake of 600 shares — an estimated $26K sold.
Tower Research Capital (TRC) first reported a position in SBV in Q1 2014 and held it in 1 quarter. The position peaked at $26K in Q1 2014. 1 fund tracked by Wall St. Rank holds SBV as of Q2 2014.
- Tower Research Capital (TRC) reported no remaining iPath Pure Beta S&P GSCI-Weighted ETN position as of Q2 2014 after selling out during the quarter.
- Tower Research Capital (TRC) sold 600 iPath Pure Beta S&P GSCI-Weighted ETN shares in Q2 2014, an estimated $26K.
- Tower Research Capital (TRC) first reported a position in iPath Pure Beta S&P GSCI-Weighted ETN in Q1 2014 and held it in 1 quarter.
- Tower Research Capital (TRC)'s iPath Pure Beta S&P GSCI-Weighted ETN position peaked at $26K in Q1 2014.
- 1 fund tracked by Wall St. Rank held iPath Pure Beta S&P GSCI-Weighted ETN as of Q2 2014.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2014, filed 14 Aug 2014.